Drug Discovery International

Drug Discovery International is published quartely by fidelio publishing as an innovative not-for-profit open access academic publishing association based in Basel, Switzerland. Working on a membership basis, we separate the payment from the publication and can afford a rigorous peer-review process with no economic pressure. Editor-in-Chief:

Dr Bhupinder Bhullar, Novartis Pharma AG (Basel, Switze

rland)

Editorial Board:

Dr Neil Carragher, Edinburgh Cancer Research Centre (Edinburgh, United Kingdom)

Dr John Harris, Cjh Consultants (Eynsford, United Kingdom)
Prof Alexander Hillisch, Bayer HealthCare AG (Wuppertal, Germany)

Dr Christopher E. Mason, Department of Physiology and Biophysics and the Institute for Computational Biomedicine, Weill Cornell Medical College, Cornell University (New York, United States)

Dr Claudia McGinnis, F. Hoffmann-La Roche AG (Basel, Switzerland)

Dr Enrico Schmidt, Novartis Institutes for Biomedical Research (Basel, Switzerland)

Prof Arne Skerra, Technical University of Munich (Munich, Germany)

Prof Michael Sundström, Karolinska Development AB (Solna, Sweden)

Managing Editor:

Sascha Grimmer, University of Basel (Basel, Switzerland)